| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | 0.1 |
| Gross profit | 0.1 | 0.0 |
| Profit before tax | -0.7 | -0.7 |
| Net income | -0.7 | -0.7 |
| EPS (diluted, $ a share) | $-0.01 | $-0.01 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +53.3% |
|---|---|
| Gross margin | 97.8% |
Source
Read the filing ↗
10-Q filed with the SEC, OTC: GTHP. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Guided Therapeutics Inc: key numbers
- Share price
- $0.1100Close, Nov 13
- Market cap
- $10.8M
- Shares outstanding
- 98.19MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Electromedical & Electrotherapeutic ApparatusSIC 3845
Today's reference numbers, updated daily. Not a valuation or a recommendation.